Here's Why Mallinckrodt Dropped 12% Today
Positive clinical-trial results couldn't save the embroiled biotech.
Mallinckrodt
MNK
MNK
$4.08
-$0.01
-0.2%
BATS BZX Real Time Price as of August 16, 2019, 4:00 p.m. EDT
View Interactive MNK Charts
Mallinckrodt plc Ordinary Shares
News & Analysis: Mallinckrodt
The Fool has written over 100 articles on Mallinckrodt.
Mallinckrodt (MNK) Q2 2019 Earnings Call Transcript
MNK earnings call for the period ending June 30, 2019.
Why Mallinckrodt Stock Is Dropping Today
The drugmaker's decision to suspend efforts to spin off its specialty generics business appears to be rattling investors.
Why Mallinckrodt Stock Is Sliding Again Today
Worrisome information from a major opioid case appears to be weighing on the drug stock.
Why Mallinckrodt Stock Is Sinking Today
Another bump in the road for Acthar is weighing on the drugmaker.
3 Drug Stocks With Unimaginably Low P/E Ratios
These drug developers are all valued at less than four times this year's projected earnings per share.
Why J.C. Penney, Mallinckrodt, and BioCryst Pharmaceuticals Slumped Today
Tough conditions for these companies left them out of the day's rally.
Why Mallinckrodt Stock Is Tanking Today
The company filed a lawsuit to stop a federal decision that could be very bad news for its top drug.
Here's Why Generic-Drug Manufacturers Were Down Monday
Forty-four states have brought a lawsuit against the industry.
Mallinckrodt (MNK) Q1 2019 Earnings Call Transcript
MNK earnings call for the period ending March 31, 2019.
